microRNA profiling in patients with abdominal aortic aneurysms: The significance of miR-155

Clinical Science

Volumn 126, Issue 11, 2014, Pages 795-803

  Biros, Erik ^a   Moran, Corey S ^a   Wang, Yutang ^a   Walker, Philip J ^b   Cardinal, John ^c   Golledge, Jonathan ^a,d  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d TOWNSVILLE HOSPITAL   (Australia)

Author keywords

Abdominal aortic aneurysm; MiR 155; miRNA; Transcript expression analysis; Vascular disease

Indexed keywords

ADULT; AGED; AORTA; AORTIC ANEURYSM, ABDOMINAL; BIOPSY; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84894422143     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130599     Document Type: Article

References (51)

1. Golledge, J., Muller, J., Daugherty, A. and Norman, P. (2006) Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 26, 2605-2613.
2. Golledge, J. and Norman, P. E. (2009) Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management. Curr. Opin. Cardiol. 24, 532-538.
3. Golledge, J. and Norman, P. E. (2011) Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 217, 57-63.
4. Golledge, J. and Kuivaniemi, H. (2013) Genetics of abdominal aortic aneurysm. Curr. Opin. Cardiol. 28, 290-296.
5. Helgadottir, A., Thorleifsson, G., Magnusson, K. P., Grétarsdottir, S., Steinthorsdottir, V., Manolescu, A., Jones, G. T., Rinkel, G. J., Blankensteijn, J. D., Ronkainen, A. et al. (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat. Genet. 40, 217-224.
6. Bown, M. J., Braund, P. S., Thompson, J., London, N. J. M., Samani, N. J. and Sayers, R. D. (2008) Association between the CAD risk locus on chromosome 9p21.3 and AAA. Circ. Cardiovasc. Genet. 1, 39-42.
7. Thompson, A. R., Golledge, J., Cooper, J. A., Hafez, H., Norman, P. E. and Humphries, S. E. (2008) Sequence variant on 9p21 is associated with the presence of AAA disease but does not have an impact on aneurysmal expansion. Eur. J. Hum. Genet. 17, 391-394.
8. Farh, K. K., Grimson, A., Jan, C., Lewis, B. P., Johnston, W. K., Lim, L. P., Burge, C. B. and Bartel, D. P. (2005) The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310, 1817-1821.
9. Pasquinelli, A. E., Hunter, S. and Bracht, J. (2005) MicroRNAs: a developing story. Curr. Opin. Genet. Dev. 15, 200-205.
10. van Rooij, E. (2011) The art of microRNA research. Circ. Res. 108, 219-234.
11. Creemers, E. E., Tijsen, A. J. and Pinto, Y. M. (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ. Res. 110, 483-495.
12. Golledge, J., Clancy, P., Moran, C., Biros, E., Rush, C., Walker, P. and Norman, P. (2010) The novel association of the chemokine CCL22 with abdominal aortic aneurysm. Am. J. Pathol. 176, 2098-2106.
13. Li, Y. and Kowdley, K. V. (2012) Method for microRNA isolation from clinical serum samples. Anal. Biochem. 431, 69-75.
14. Parr, A., Jayaratne, C., Buttner, P. and Golledge, J. (2011) Comparison of volume and diameter measurement in assessing small abdominal aortic aneurysm expansion examined using computed tomographic angiography. Eur. J. Radiol. 79, 42-47.
15. Golledge, J., Muller, J., Shephard, N., Clancy, P., Smallwood, L., Moran, C., Dear, A. E., Palmer, L. J. and Norman, P. E. (2007) Association between osteopontin and human abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 27, 655-660.
16. Golledge, J., Clancy, P., Jamrozik, K. and Norman, P. E. (2007) Obesity, adipokines, and abdominal aortic aneurysm: Health in Men study. Circulation 116, 2275-2279.
17. Joehanes, R., Ying, S., Huan, T., Johnson, A. D., Raghavachari, N., Wang, R., Liu, P., Woodhouse, K. A., Sen, S. K., Tanriverdi, K. et al. (2013) Gene expression signatures of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 33, 1418-1426.
18. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57, 289-300.
19. Sonkoly, E., Janson, P., Majuri, M. L., Savinko, T., Fyhrquist, N., Eidsmo, L., Xu, N., Meisgen, F., Wei, T., Bradley, M. A. et al. (2010) MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J. Allergy Clin. Immunol. 126, 581-589.
20. Louafi, F., Martinez-Nunez, R. T. and Sanchez-Elsner, T. (2010) MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β. J. Biol. Chem. 285, 41328-41336.
21. Kozomara, A. and Griffiths-Jones, S. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152-D157.
22. Liu, D. Z., Tian, Y., Ander, B. P., Xu, H., Stamova, B. S., Zhan, X., Turner, R. J., Jickling, G. and Sharp, F. R. (2010) Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J. Cereb. Blood Flow Metab. 30, 92-101.
23. Ceolotto, G., Papparella, I., Bortoluzzi, A., Strapazzon, G., Ragazzo, F., Bratti, P., Fabricio, A. S., Squarcina, E., Gion, M., Palatini, P. and Semplicini, A. (2011) Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am. J. Hypertens. 24, 241-246.
24. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C. W., Röxe, T., Müller-Ardogan, M. et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ. Res. 107, 677-684.
25. Corsten, M. F., Papageorgiou, A., Verhesen, W., Carai, P., Lindow, M., Obad, S., Summer, G., Coort, S. L., Hazebroek, M., van Leeuwen, R. et al. (2012) MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ. Res. 111, 415-425.
26. Zhu, J., Chen, T., Yang, L., Li, Z., Wong, M. M., Zheng, X., Pan, X., Zhang, L. and Yan, H. (2012) Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10. PLoS ONE 7, e46551.
27. Pahl, M. C., Derr, K., Gäbel, G., Hinterseher, I., Elmore, J. R., Schworer, C. M., Peeler, T. C., Franklin, D. P., Gray, J. L., Carey, D. J. et al. (2012) MicroRNA expression signature in human abdominal aortic aneurysms. BMC Med. Genomics 5, 25.
28. Kin, K., Miyagawa, S., Fukushima, S., Shirakawa, Y., Torikai, K., Shimamura, K., Daimon, T., Kawahara, Y., Kuratani, T. and Sawa, Y. (2012) Tissue-and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc. 1, e000745.
29. Goodall, S, Crowther, M, Hemingway, DM, Bell, PR and Thompson, MM. (2001) Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation 104, 304-309.
30. Kuivaniemi, H., Platsoucas, C. D. and Tilson, III, M. D. (2008) Aortic aneurysms: an immune disease with a strong genetic component. Circulation 117, 242-252.
31. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A. and Baltimore, D. (2010) Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10, 111-122.
32. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B. and Bluestone, J. A. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
33. O'Connell, R. M., Kahn, D., Gibson, W. S., Round, J. L., Scholz, R. L., Chaudhuri, A. A., Kahn, M. E., Rao, D. S. and Baltimore, D. (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619.
34. Walker, L. S. and Sansom, D. M. (2011) The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nat. Rev. Immunol. 11, 852-863.
35. Lenk, G. M., Tromp, G., Weinsheimer, S., Gatalica, Z., Berguer, R. and Kuivaniemi, H. (2007) Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 8, 237.
36. Carreno, B. M. and Collins, M. (2002) The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20, 29-53.
37. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
38. Magistrelli, G., Jeannin, P., Herbault, N., Benoit De Coignac, A., Gauchat, J. F., Bonnefoy, J. Y. and Delneste, Y. (1999) A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur. J. Immunol. 29, 3596-3602.
39. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
40. Lenk, G. M., Tromp, G., Skunca, M., Gatalica, Z., Berguer, R. and Kuivaniemi, H. (2006) Global expression profiles in human normal and aneurysmal abdominal aorta based on two distinct whole genome microarray platforms. Ann. N.Y. Acad. Sci. 1085, 360-362.
41. Choke, E., Cockerill, G. W., Laing, K., Dawson, J., Wilson, W. R., Loftus, I. M. and Thompson, M. M. (2009) Whole genome-expression profiling reveals a role for immune and inflammatory response in abdominal aortic aneurysm rupture. Eur. J. Vasc. Endovasc. Surg. 37, 305-310.
42. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. and Burge, C. B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798.
43. Wang, Y., Ait-Oufella, H., Herbin, O., Bonnin, P., Ramkhelawon, B., Taleb, S., Huang, J., Offenstadt, G., Combadière, C., Rénia, L. et al. (2010) TGF-β activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J. Clin. Invest. 120, 422-432.
44. Defawe, O. D., Colige, A., Lambert, C. A., Munaut, C., Delvenne, P., Lapière, C. M., Limet, R., Nusgens, B. V. and Sakalihasan, N. (2003) TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc. Res. 60, 205-213.
45. DiMusto, P. D., Lu, G., Ghosh, A., Roelofs, K. J., Su, G., Zhao, Y., Lau, C. L., Sadiq, O., McEvoy, B., Laser, A. et al. (2012) Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am. J. Physiol. Heart Circ. Physiol. 302, H1378-H1386.
46. Maegdefessel, L., Azuma, J., Toh, R., Deng, A., Merk, D. R., Raiesdana, A., Leeper, N. J., Raaz, U., Schoelmerich, A. M., McConnell, M. V. et al. (2012) MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci. Transl. Med. 4, 122ra22.
47. Dey, N., Ghosh-Choudhury, N., Kasinath, B. S. and Choudhury, G. G. (2012) TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion. PLoS ONE 7, e42316.
48. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y. and Ochiya, T. (2010) Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285, 17442-17452.
49. Haasch, D., Chen, Y. W., Reilly, R. M., Chiou, X. G., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W. et al. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell. Immunol. 217, 78-86.
50. Bown, M. J., Nicholson, M. L., Bell, P. R. and Sayers, R. D. (2003) The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair. J. Vasc. Surg. 37, 600-606.
51. Golledge, A. L., Walker, P., Norman, P. E. and Golledge, J. (2009) A systematic review of studies examining inflammation associated cytokines in human abdominal aortic aneurysm samples. Dis. Markers 26, 181-188.